Chemodex

Hydrocortisone

As low as CHF 45.00
In stock
Only %1 left
CDX-H0269-G0011 gCHF 45.00
CDX-H0269-G0055 gCHF 103.00
CDX-H0269-G02525 gCHF 309.00
NEW
 
More Information
Product Details
Synonyms 11β17α 21-Trihydroxypregn-4-ene-3,20-dione; Cortisol; Dihydrocostisone; NSC 10483; Kendall's compound F; Reichstein's substance M
Product Type Chemical
Properties
Formula C21H30O5
MW 362.46
CAS 50-23-7
RTECS GM8925000
Source/Host Chemicals Synthetic
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO (20mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key JYGXADMDTFJGBT-VWUMJDOOSA-N
Smiles O=C1CC[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(O)C(CO)=O)=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
Hydrocortisone is a glucocorticoid produced by the adrenal cortex in response to adrenocorticotropic hormone (ACTH). Hydrocortisone has three times the anti-inflammatory potency of corticosterone but much lower Na+ retention potency. It is an agonist at the mineralocorticoid receptor (MR) and the glucocorticoid receptor. Hydrocortisone plays a role in the regulation of metabolism, electrolyte balance, water balance, and the body's stress response. Hydrocortisone production is increased during periods of stress, and it is a major effector molecule in the hypothalamic-pituitary-adrenal axis (HPA) stress response. Cortisol levels increase with age and are often elevated in major depressive disorder, certain forms of hypertension, and Parkinson's disease. It has been utilized in research to investigate the impact of inflammation and stress on cellular processes.
Product References
(1) D.T. Matulich, et al.; J. Clin. Endocrinol. Metab. 43, 1170 (1976) | (2) P.E. Stokes; Eur. Neuropsychopharmacol. 5, 77 (1995) | (3) F.P. Varghese & E.S. Brown; Prim. Care Companion. J. Clin. Psychiatry 3, 151 (2001) | (4) M. Quinkler & P.M. Stewart; J. Clin. Endocrinol. Metab. 88, 2384 (2003) | (5) J. Nijm & L. Jonasson; Ann. Med. 41, 224 (2009) | (6) S. Paredes & L. Ribeiro; Rev. Assoc. Med. Bras. 60, 84 (2014) | (7) D.J. van Wamelen, et al.; Int. Rev. Neurobiol. 152, 131 (2020)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.